Baxter International’s largest manufacturing plant is back up to regular production levels nearly five months after it was ...

Baxter International shares surged Thursday after the medical device maker's fourth-quarter results topped estimates.

A Baxter International intravenous manufacturing plant in North Carolina is back up and running at full capacity after it ...

Baxter International (BAX) stock gains as the firm beats with Q4 & full-year results thanks to strong overseas sales and ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its financial guidance for first-quarter ...

Baxter's North Cove manufacturing facility in Marion, N.C., has returned to pre-hurricane production levels following extensive flooding from Hurricane Helene, which halted operations and triggered a ...

Discover Baxter International's Q4 2024 earnings insights, including recovery milestones, Novum IQ pump success, and a promising 2025 growth outlook.

Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract.

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

The Deerfield, Illinois-based medtech company reported losses of $512 million. That equals $1 per share on sales of $2.75 ...

Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...